Log In
Print this Print this

talimogene laherparepvec (formerly OncoVEX GM-CSF)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionModified herpes simplex virus type 1 (HSV-1) encoding GM-CSF
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentRegistration
Standard IndicationMelanoma
Indication DetailsTreat melanoma; Treat metastatic melanoma
Regulatory Designation

U.S. - Special Protocol Assessment (Treat metastatic melanoma);
U.S. - Standard Review (Treat metastatic melanoma);
EU - Standard Review (Treat metastatic melanoma)


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today